PD-L1 Dysregulation in COVID-19 Patients
Immunology
[키워드] Adaptive immune response
ARDS
biological sample
blood sample
caused
CD4+ T cells
clinical study
consequence
COVID-19
COVID-19 pandemic
COVID-19 pathogenesis
COVID-19 patient
cultures
dysregulated
dysregulated immune response
dysregulation
effective
epithelial cell
Evidence
healthy donors
healthy individuals
hospitalized COVID-19 patient
Host immune response
identify
Immune cell
immune checkpoint molecules
in vitro
Infection
inhibitors
innate immune response
Ligand
manifestation
Manifestations
model system
modulation
Monocytes
Neutrophils
Patient
PD-L1
Prognosis
prognostic
prognostic biomarker
reached
RNA expression
SARS-CoV-2
Serum level
subset
T cell
therapeutic approaches
tissue
tissue biopsy
upregulation
variety
[DOI] 10.3389/fimmu.2021.695242 PMC 바로가기 [Article Type] Immunology
[DOI] 10.3389/fimmu.2021.695242 PMC 바로가기 [Article Type] Immunology